Success Metrics

Clinical Success Rate

66.7%

Based on 2 completed trials

Completion Rate

67%(2/3)

Active Trials

0(0%)

Results Posted

50%(1 trials)

Terminated

1(33%)

Phase Distribution

Ph phase_4

33%

Ph not_applicable

67%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 4Post-market surveillance

1(33.3%)

N/ANon-phased studies

2(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(2)

Terminated(1)

Detailed Status

Completed2

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

66.7%

Most Advanced

Phase 4

Trials by Phase

Phase 41 (33.3%)

N/A2 (66.7%)

Trials by Status

completed267%

terminated133%

Recent Activity

0 active trials

Showing 3 of 3

completedphase_4

Intima Versus Adventitia Drug Delivery to Elucidate Mechanisms of Restenosis: Magnetic Resonance Imaging

NCT02807779

terminatednot_applicable

Drug Coated Balloons vs Plain Balloons for the Management of Dysfunctional Dialysis Fistula

NCT03189667

completednot_applicable

PTA vs. CB-PTA for Treatment of Femoropopliteal Artery In-Stent Restenosis

NCT00481780

Clinical Trials (3)

Showing 3 of 3 trials

NCT02807779Phase 4

Intima Versus Adventitia Drug Delivery to Elucidate Mechanisms of Restenosis: Magnetic Resonance Imaging

Completed

NCT03189667Not Applicable

Drug Coated Balloons vs Plain Balloons for the Management of Dysfunctional Dialysis Fistula

Terminated

NCT00481780Not Applicable

PTA vs. CB-PTA for Treatment of Femoropopliteal Artery In-Stent Restenosis

Completed

All 3 trials loaded

Drug Details

Intervention Type: DEVICE
Total Trials: 3